Skip to content
MarketNewsAPI
Live news Screener Coverage Pricing Docs REST API WebSocket API MCP server Company Use cases Blog Changelog Status Compare Contact
Log in Get API key Dashboard
ALGRF$0.400.00(0.00%)Algo Grande Commissions Independent NI 43-101 Update to Capture First Year of Progress at Adelita[5:30:00 PM ET]ZEFIF$0.45+0.02(+3.56%)Zefiro Announces Closing of Non-Brokered Private Placement for Gross Proceeds of Approximately C$5.0 Million[5:29:00 PM ET]BLK$1,118.50-18.79(-1.65%)BlackRock® Canada Announces the Termination of iShares Convertible Bond Index ETF[5:23:34 PM ET]ITFS$1.43-0.02(-1.10%)Itafos Announces Release Date for Q3 2026 Results and Business Update Webcast[5:15:00 PM ET]FAGI$0.01-0.00(-13.33%)Full Alliance Group, Inc (OTC:FAGI) YAHBEE Highlights Community-Commerce Model for Agentic Commerce Era[5:15:00 PM ET]TGT$152.76-5.35(-3.38%)Vital Farms Introduces a Higher Standard for Free-Range Eggs Through Limited Pilot at Select Target Retail Stores[5:05:00 PM ET]NU$15.24+0.51(+3.46%)Notice to Market: Nu Holdings Ltd.[5:03:00 PM ET]POR$44.55-0.35(-0.78%)Portland General Electric Declares Dividend[5:00:00 PM ET]ANTX$3.55-0.09(-2.47%)AN2 Therapeutics, Inc. Reports Inducement Grants Under Listing Rule 5635(c)(4)[5:00:00 PM ET]EML$24.18-0.67(-2.70%)The Eastern Company Announces Timing of Third Quarter 2026 Earnings Release and Conference Call[4:55:00 PM ET]MYE$32.13-0.70(-2.13%)Myers Industries Announces Quarterly Dividend[4:45:00 PM ET]FCAP$63.35-0.59(-0.92%)First Capital, Inc. Reports Quarterly Earnings[4:45:00 PM ET]AIRDF$0.33-0.01(-3.96%)Rocket Doctor Grants Equity[4:42:20 PM ET]

ABBV · NYSE

AbbVie Inc.

$285.64 +1.02 (+0.36%)

Company overview

AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheumatoid arthritis in adult patients; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL); and VENCLEXTA, a BCL-2 inhibitor used to treat adults with CLL or SLL.

Sector
Healthcare
Industry
Drug Manufacturers - General
Exchange
NYSE
Market cap
$505B
Employees
55,000
Headquarters
North Chicago, IL
Website
abbvie.com
CEO
Robert A. Michael
Listed
January 2, 2013
P/E
140.05
Dividend yield
2.55%

Company financials

Revenue
$62.8B
Gross profit
$44.4B
Operating income
$17.3B
EBITDA
$16.9B
Net income
$3.6B
EPS
$2.04
Total assets
$136B
Total debt
$72.9B
Gross margin
70.68%
Net margin
5.79%
Earnings yield
0.71%

Revenue segmentation

By product (FY 2025)
By region (FY 2025)

Showing FY 2025

Price chart

186.72213.90241.08268.25295.43
ABBV 1D NYSE O284.57H285.76L278.01C285.19+0.39 (+0.14%)Vol6.17M

News

15-min delaySigned-out view is delayed 15 minutes. Log in on Pro for the live news desk.

Start 7-day free trial See live plans
Source
Date
Type
Ticker Type Headline Source Published
ABBV Press release U.S. FDA Approves Subcutaneous Induction Regimen for AbbVie's SKYRIZI® (risankizumab-rzaa) for Adults With Moderately to Severely Active Crohn's Disease AbbVie (NYSE: ABBV) today announced the U.S. PR Newswire
ABBV Stock news AbbVie's Dividend Survived Humira's Patent Cliff. Will Merck and Amgen's? 24/7 Wall Street
ABBV Stock news Forget Chasing 7% Yields: These 5 Dividend Stocks Offer Something Different 24/7 Wall Street
ABBV Stock news The Dividend Aristocrats Ranked By Quality Scores (October 2026) Seeking Alpha
ABBV Stock news AbbVie (ABBV) Earnings Expected to Grow: What to Know Ahead of Next Week's Release Zacks Investment Research
ABBV Stock news 6,790 AbbVie Inc. $ABBV Shares Sold by AMF Tjanstepension AB Defense World
ABBV Stock news What Higher Interest Rates Mean for Dividend Stocks Like AbbVie and Pfizer The Motley Fool
ABBV Stock news Great News for AbbVie Stock Investors The Motley Fool
ABBV Stock news AbbVie (ABBV) Is Considered a Good Investment by Brokers: Is That True? Zacks Investment Research
ABBV Stock news AbbVie's skin disease drug reduces lesions in trial, company eyes weight-loss combination Reuters
ABBV Stock news JNJ Stock Has a New Growth Story, but One Business Needs to Catch Up 24/7 Wall Street
ABBV Press release AbbVie Announces Topline Results from the Phase 3 INTREPID Trial Showing Lutikizumab Significantly Improved Signs and Symptoms of Disease in Patients with Hidradenitis Suppurativa PRNewsWire
ABBV Press release Allergan Aesthetics Deepens Science Behind Multimodal Approach at AMWC Dubai, Backed by Growing HArmonyCa™ Evidence Allergan Aesthetics, an AbbVie company (NYSE: ABBV) and a global leader in aesthetics, will showcase the latest scientific e. PR Newswire
ABBV Press release AbbVie Named Official Pharmaceutical Partner of the McLaren Mastercard Formula 1 Team, Launches AbbVie Race to Innovate to Support Immunology Community AbbVie (NYSE: ABBV), a global pharmaceutical leader, and McLaren Racing today announced . PR Newswire
ABBV Stock news 15 Undervalued Stocks: Yield Up To 7.8% And 15 Overvalued Not To Pursue Now Seeking Alpha
ABBV Stock news AbbVie's Neuroscience Franchise: What to Expect Ahead of Q3 Results Zacks Investment Research
ABBV Stock news Johnson & Johnson Stock Could Be a Defensive Play for the Years Ahead 24/7 Wall Street
ABBV Stock news 1,939 AbbVie Inc. $ABBV Shares Acquired by IFP Advisors Inc Defense World
ABBV Press release AbbVie Presents Data for ABBV-466, a Novel Dual-Targeting Therapy Demonstrating Higher Endoscopic Remission Rates Than Either Anti-IL-23 or Anti-α4β7 Monotherapy in Moderate to Severe Crohn's Disease AbbVie (NYSE: ABBV) today announced that. PR Newswire
ABBV Stock news /C O R R E C T I O N - AbbVie/ GuruFocus
See more
FAQ

Questions about AbbVie Inc.

What does AbbVie Inc. do?
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheumatoid arthritis in adult patients; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL); and VENCLEXTA, a BCL-2 inhibitor used to treat adults with CLL or SLL.
What is ABBV's market cap?
AbbVie Inc. (ABBV) is a listed stock with a live quote. The latest market cap on this page is $505B.
Where is AbbVie Inc. headquartered?
AbbVie Inc. is headquartered in North Chicago, IL.
How do I get ABBV news from the API?
Call GET /v1/news?tickers=ABBV. Add type=news, type=press_release, or type=legal to take one feed. Pro keys search the full archive in real time. Free keys are delayed 15 minutes and return the last year. Signed-out visitors and Free accounts see that same year on this page. Pro sees the full archive.
How far back does ABBV news go?
Signed-out visitors and Free accounts see the last year of stock news, press releases, and legal notices for ABBV, 15 minutes behind, and each headline links to the publisher. Pro, including the 7-day trial, sees the full archive as headlines are ingested. A Free API key returns the last year. Pro keys search the full archive.
Is the ABBV price on this page from the API?
The price and daily change update during the US session for every visitor. That quote is context on this page. It is not part of the news API. The chart is one candle per session from the start of 2020. 1W, 1M, and 1Y group those sessions.

Real-time stock news for $15 a month.

Start a 7-day Pro trial. A card is required. REST, WebSocket, and MCP are included. If you don't subscribe, the account stays on Free.

Start 7-day free trial Read the docs